Increased waiting time does not affect patients QoL for those awaiting THA .
The effect of waiting time on health and quality of life outcomes and costs of medication in hip replacement patients: A randomized clinical trial
Osteoarthritis Cartilage. 2009 Sep;17(9):1144-50. Epub 2009 Apr 1.395 patients undergoing total hip replacement (THR) were randomized to one of two waiting time groups. The first group (short waiting time) received surgery within the first 3 months of randomization. The second group (non-fixed waiting time) received surgery any time after 3 months. This study assessed differences in health related quality of life, pain, function, and cost between the two groups. The results collected at 12 months postoperatively indicated that the length of waiting time had no significant impact on the weekly use and cost of medication, and hip functional outcomes. However, a shorter waiting period significantly lowered the total cost of analgesics and anti-inflammatory drugs used preoperatively.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!